)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
OPKO Health
OPKO Health (OPK) investor relations material
OPKO Health Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary8 May, 2026
Therapeutics pipeline and proprietary technologies
Advancing a robust pipeline with five clinical-stage and five pre-IND assets, including multispecific antibodies and nanoparticle vaccines targeting oncology, immunology, and viral diseases.
ModeX platforms validated through partnerships and clinical-stage programs, offering greater specificity and broad applications.
Lead programs include EBV nanoparticle vaccine, multispecific immune rejuvenators, and long-acting biologics for metabolic and autoimmune disorders.
Strategic partnerships and business development
Collaborations with Merck, BARDA, Regeneron, Pfizer, and Entera Bio provide up to $1B in milestone payments and royalties.
Pfizer partnership for NGENLA enables global commercialization and significant profit share.
Regeneron partnership leverages MSTAR platform for multispecific antibody discovery, with Regeneron funding all R&D and commercial activities.
Pharmaceutical and diagnostics business performance
Specialty pharmaceuticals, including Rayaldee, show steady sales growth and positive cash flow, supporting R&D investments.
BioReference Health streamlined through asset divestitures, generating up to $462.5M in cash and focusing on core clinical testing in NY/NJ.
4Kscore Test positioned for increased utilization and market share in diagnostics.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from OPKO Health
- Proxy seeks approval for director elections, new equity plan, executive pay, and auditor ratification.OPK
Proxy filing30 Apr 2026 - Key votes include board elections, equity plan approval, say-on-pay, and auditor ratification.OPKProxy filing30 Apr 2026
- Q1 2026 revenue fell, but losses narrowed and liquidity and clinical progress remained strong.OPKQ1 202628 Apr 2026
- Q4 2025 saw revenue decline from divestitures, but R&D progress and cash strength support future growth.OPKQ4 20257 Apr 2026
- Q2 2024 saw lower revenue but improved net loss, with major financing and asset sale moves.OPKQ2 20242 Feb 2026
- Diagnostics restructuring, pipeline progress, and strategic partnerships drive near-term growth.OPKJefferies 2024 Global Healthcare Conference1 Feb 2026
- Q3 2024 posted $24.9M net income, asset sale gains, and expanded BARDA funding.OPKQ3 202415 Jan 2026
- Therapeutics-focused strategy, key partnerships, and innovative pipeline drive growth.OPK44th Annual J.P. Morgan Healthcare Conference14 Jan 2026
- Advancing a broad clinical pipeline and global partnerships, with strong financial discipline.OPKCorporate presentation14 Jan 2026
Next OPKO Health earnings date
Q2 202630 Jul, 2026
OPKO Health
Next OPKO Health earnings date
Q2 202630 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage